US biotechnology company Moderna is relocating its UK commercial headquarters to TRIBECA, a life sciences and innovation campus in King’s Cross, London.
The mRNA medicines developer will occupy approximately 4,206 sqft at The Reflector, a building on the TRIBECA campus being developed by Reef + Partners and BlackRock Real Estate.
The space will be delivered on a fully fitted basis, with the design developed in collaboration with Moderna to meet the company’s requirements.
Fit-out works are expected to be completed by the end of April 2027.
The move will expand Moderna’s London presence and complement its existing UK facilities, including the Moderna Innovation and Technology Centre at Harwell Campus in Oxfordshire.
TRIBECA is being delivered in two phases, with its first phase, The Apex, comprising more than 110,000 sqft of laboratory space.
The London BioScience Innovation Centre (LBIC) has taken 33,000 sqft at the development, while the Francis Crick Institute is collaborating on a further 52,000 sqft of space.
Located within London’s Knowledge Quarter, the campus provides laboratory and innovation facilities alongside access to research institutions and national and international transport links.
"With TRIBECA positioned at the heart of London’s Knowledge Quarter, it puts us in close proximity to many of the country’s leading scientific and research institutions, making it a great environment for our continued growth and the further development of our mRNA platform,” said Darius Hughes, UK General Manager at Moderna.
